Covered recipient · General Payments record
ALESSANDRA FERRAJOLI
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$72,485.38
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $9,212.50 | 3 |
| Food and Beverage | $792.37 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $4,664.41 | 3 |
| Janssen Global Services, LLC | $2,452.50 | 1 |
| BeiGene USA, Inc. | $2,389.18 | 3 |
| PFIZER INC. | $276.83 | 3 |
| Lilly USA, LLC | $169.43 | 2 |
| ABBVIE INC. | $26.61 | 1 |
| GlaxoSmithKline, LLC. | $25.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.61 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103723438 | CMS |
| AstraZeneca Pharmaceuticals LP | $94.41 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110543687 | CMS |
| AstraZeneca Pharmaceuticals LP | $60.00 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110544825 | CMS |
| AstraZeneca Pharmaceuticals LP | $4,510.00 | 12/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110550538 | CMS |
| BeiGene USA, Inc. | $2,250.00 | 04/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120847713 | CMS |
| BeiGene USA, Inc. | $104.04 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120847717 | CMS |
| BeiGene USA, Inc. | $35.14 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120847715 | CMS |
| GlaxoSmithKline, LLC. | $25.91 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116387880 | CMS |
| Janssen Global Services, LLC | $2,452.50 | 01/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077592357 | CMS |
| Lilly USA, LLC | $68.00 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136018169 | CMS |
| Lilly USA, LLC | $101.43 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136018171 | CMS |
| PFIZER INC. | $83.91 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131306578 | CMS |
| PFIZER INC. | $118.35 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131346123 | CMS |
| PFIZER INC. | $74.57 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131388497 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.